(Q38017871)

27 August 2017

title

Inflammatory bowel disease: role of diet, microbiota, life style (English)

1 reference

inflammatory bowel diseases

27 August 2017

main subject

0 references

inflammation

0 references

author name string

Manuela G Neuman

series ordinal

1

1 reference

27 August 2017

Radu M Nanau

series ordinal

2

1 reference

27 August 2017

publication date

24 September 2011

1 reference

27 August 2017

published in

Translational Research

1 reference

27 August 2017

volume

160

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

29-44

1 reference

Immune dysfunction in inflammatory bowel disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Uncoupling gene-diet interactions in inflammatory bowel disease (IBD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Inflammatory bowel disease, gut bacteria and probiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Environmental risk factors in Crohn's disease and ulcerative colitis: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

New insights into IBD epidemiology: Are there any lessons for treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Epidemiology of Inflammatory Bowel Disease among Children in Poland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Characteristics of inflammatory bowel disease with onset during the first year of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

CEACAM1 and the regulation of mucosal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Targeted therapies in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Inflammatory bowel disease and serum beta-N-acetylhexosaminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Colorectal polyposis and immune-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Genes, diet and inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutrition in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutritional consequences and nutrition therapy in Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutrition assessment of patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

The utilization of parenteral nutrition during the in-patient management of inflammatory bowel disease in the United States: a national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Inflammatory bowel disease and Streptococcus bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutrigenomics and gut health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

DNA-driven nutritional therapy of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Editorial: Antibiotics earlier, IBD later?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Antibiotic use and inflammatory bowel diseases in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.001

10.1016/J.TRSL.2011.09.001

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference